ADVERTISEMENT

Podcast

Podcast: Meet Grace, The Clinical Trial AI Agent

In Vivo spoke with Tran Le and Sohit Gatiganti, co-founders of Grove AI and developers of Grace, a voice-based AI agent to streamline clinical trial processes.

The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US

In the wake of multiple ustekinumab biosimilar rivals to Stelara launching in the US at the end of February, Generics Bulletin’s editors discuss the market dynamics and the latest key developments.

Podcast: Harness Therapeutics CEO Talks Somatic Expansion For Neurodegeneration

Harness Therapeutics' CEO talked to In Vivo about the company's strategy for expansion and partnering in the neurodegeneration space.

Pink Sheet Podcast: Concerns and Questions As Trump Administration Takes Control Of US FDA

Pink Sheet reporter and editors discuss the uncertainty created by the Trump Administration freezing most communications at the Health and Human Services Department, new travel and telework bans, as well as the delay in announcing an acting FDA leader and the impact of new executive orders on the FDA and CMS.

Podcast: How Fauna Bio Gleans Therapeutic Insights From Animals

In Vivo speaks with Ashley Zehnder, CEO of Fauna Bio, a company using AI to identify drug targets based on natural disease resistance in animals.

Podcast: Pre-JPM Biotech Dealmaking Panel

As we enter 2025, In Vivo convened a group of biotech executives for a wide-ranging conversation about dealmaking this year and the challenges and opportunities for companies in the cardiometabolic, longevity, radiopharmaceuticals and cancer spaces. Essential listening before JPM.

The Generics Bulletin Podcast: Highlights Of 2024

Generics Bulletin's editorial team discusses key topics from the year, including the latest rankings of the Generics Bulletin Top 50, Amgen’s surprise launch of a US Eylea biosimilar, the EU’s Urban Waste Water Treatment Directive and supply-chain issues for the off-patent sector.

Podcast: Treating Rare Diseases With tRNA

In this episode of the In Vivo podcast Michelle Werner, CEO of Alltrna, discusses using tRNA as a therapeutic modality for rare diseases.

Podcast: Mapping The Immune System To Predict Immune Responses

Israeli-American biotech Immunai is mapping the immune system and using AI to predict immune responses to drugs.